BUE Equity Snapshot

RICH Weekly Equity Report

Laboratorios Richmond S.A.C.I.F.

Interactive chart JSON snapshot
Latest Close 1,600 ARS 12 Jun 2026
1W Return 1.0% latest completed week
4W Return 3.3% short-term follow-through
12W Return -3.2% quarterly tape
Trend Breadth 16.7% 8 of 48 weeks active
Volume Ratio - vs 13-week average
Company Brief

What the company does

Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company was incorporated in 1959 and is headquartered in Buenos Aires, Argentina.

Snapshot

What the weekly tape is saying

RICH closed the latest completed week at 1,600 ARS. The 4-week return is 3.3% and the 12-week return is -3.2%. Trend Signal is inactive, Market Dynamics is -0.59. Setup signature: Risk-first tape with a 31/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -9.3%
Volume -
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 9 Persistence of active Trend Signal over the last year and current streak.
Momentum 55 Blend of 4-week and 12-week follow-through.
Dynamics 43 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 50 Relative leadership and short-term RS change.
Volume 0 Participation compared with the 13-week volume baseline.
Risk Control 27 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
1,764 ARS
Vs Trend Line
-9.3%
Fair Value
1,569 ARS
Vs Fair Value
2.0%
52W High
2,193 ARS
52W Low
945.5 ARS
Drawdown
-27.0%
Range Position
52.5%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 1.0%
4W 3.3%
12W -3.2%
26W -24.8%
52W -

Trend read

Active Streak
0 weeks
52W Active Weeks
8
52W Active Breadth
16.7%
Sector Scope
AR Healthcare
Sector Rank
5 of 20
Sector Percentile
78.9%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-0.59
4W MD Change
41.2%
Relative Strength
-
4W RS Change
-
Expectation
Negative
Probability
39.06%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
0
13W Average
158
52W Average
939
Vs 13W
-
Vs 52W
-
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.5%
52W Volatility
8.0%
Upside Weeks
20
Downside Weeks
23
Downside Breadth
48.9%
Avg Gain / Loss
7.8% / -5.4%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
BUE
Country
AR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
ARS
Market Cap
131.2B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 1,600 ARS 1.0% 1,764 ARS 1,569 ARS -0.59 - 0 Off
5 Jun 2026 1,583 ARS 0.0% 1,765 ARS 1,569 ARS -0.74 - 0 Off
29 May 2026 1,583 ARS 0.0% 1,763 ARS 1,568 ARS -0.87 - 0 Off
22 May 2026 1,583 ARS 2.2% 1,758 ARS 1,568 ARS -0.96 - 65 Off
15 May 2026 1,549 ARS -1.8% 1,743 ARS 1,568 ARS -1.00 - 75 Off
8 May 2026 1,577 ARS 1.3% 1,727 ARS 1,568 ARS -0.94 - 184 Off
1 May 2026 1,558 ARS 0.6% 1,712 ARS 1,568 ARS -0.82 - 65 Off
24 Apr 2026 1,548 ARS -5.7% 1,695 ARS 1,568 ARS -0.84 - 138 Off
17 Apr 2026 1,641 ARS -2.6% 1,679 ARS 1,569 ARS -0.85 - 32 Off
10 Apr 2026 1,685 ARS 8.1% 1,656 ARS 1,567 ARS -0.85 - 468 Off
3 Apr 2026 1,559 ARS -2.2% 1,636 ARS 1,564 ARS -0.86 - 25 Off
27 Mar 2026 1,594 ARS -3.6% 1,621 ARS 1,564 ARS -0.84 - 300 On
20 Mar 2026 1,653 ARS -5.1% 1,605 ARS 1,563 ARS -0.83 - 699 On
13 Mar 2026 1,742 ARS 9.7% 1,591 ARS 1,560 ARS -0.84 - 1.4K On